Multicenter analysis of treatment outcomes for well differentiated grade 3 neuroendocrine tumors (NET G3).

Published: May 20, 2020
Abstract
4607 Background: Well differentiated grade 3 neuroendocrine tumors (NET G3) have been distinguished from poorly differentiated neuroendocrine carcinomas (NEC) in the most current WHO classifications from 2017 and 2019. Retrospective data suggest that commonly applied first-line chemotherapy protocols with cisplatin or carboplatin in combination with etoposide (PE) are less effective in NET G3 than NEC. Therefore, current treatment guidelines...
Paper Details
Title
Multicenter analysis of treatment outcomes for well differentiated grade 3 neuroendocrine tumors (NET G3).
Published Date
May 20, 2020
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.